Jerome McKay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jerome McKay has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Divya Verma
National Jewish Health Denver Colorado USA
2 shared publications - Mukesh Verma
The Division of Allergy and Immunology, Department of Medicine, National Jewish Health
2 shared publications - Anand Sripada
Division of Allergy & Immunology, Department of Medicine, National Jewish Health, Denver, CO 1
1 shared publication - Brian P. O'COnnor
12Pfizer Inc., Bothell, Washington
1 shared publication - Dipa Sheth
Washington, DC
1 shared publication - Jennifer R. Knapp
Center for Genes, Environment and Health, National Jewish Health , Denver, CO
1 shared publication
Latest Publications
- 1 June 2023
- Published by Taylor & Francis in Epigenomics
- Vol. 15 (11) , 615-618
Role of Epigenetics in Innate Lymphoid Cells
Epigenetics plays a crucial role in gene regulation and cell function without changing the DNA sequence. The process of differentiation in eukaryotes during cellular morphogenesis is a paradigm of ...
- 1 June 2023
- Published by Taylor & Francis in Epigenomics
- Vol. 15 (11) , 615-618
Role of Epigenetics in Innate Lymphoid Cells
Epigenetics plays a crucial role in gene regulation and cell function without changing the DNA sequence. The process of differentiation in eukaryotes during cellular morphogenesis is a paradigm of ...
- Open Access
- 2 June 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (7)
The molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma
Repetitive exposure of Rag1−/− mice to the Alternaria allergen extract generated a form of memory that elicited an asthma-like response upon a subthreshold recall challenge 3–15 wk later. This memory was associated with lung ICOS+ST2+ ILC2s. Genetic, pharmacologic, and antibody-mediated inhibition and adoptive transfer established an essential role for ILC2s in memory-driven asthma. ATAC-seq demonstrated a distinct epigenetic landscape of memory ILC2s and identified Bach2 and AP1 (JunD and Fosl2) motifs as major drivers of altered gene accessibility. scRNA-seq, gene knockout, and signaling studies suggest that repetitive allergenic stress induces a gene repression program involving Nr4a2, Zeb1, Bach2, and JunD and a preparedness program involving Fhl2, FosB, Stat6, Srebf2, and MPP7 in memory ILC2s. A mutually regulated balance between these two programs establishes and maintains memory. The preparedness program (e.g., Fhl2) can be activated with a subthreshold cognate stimulation, which down-regulates repressors and activates effector pathways to elicit the memory-driven phenotype.
- 2 June 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (7)
Open AccessThe molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma
Repetitive exposure of Rag1−/− mice to the Alternaria allergen extract generated a form of memory that elicited an asthma-like response upon a subthreshold recall challenge 3–15 wk later. This memory was associated with lung ICOS+ST2+ ILC2s. Genetic, pharmacologic, and antibody-mediated inhibition and adoptive transfer established an essential role for ILC2s in memory-driven asthma. ATAC-seq demonstrated a distinct epigenetic landscape of memory ILC2s and identified Bach2 and AP1 (JunD and Fosl2) motifs as major drivers of altered gene accessibility. scRNA-seq, gene knockout, and signaling studies suggest that repetitive allergenic stress induces a gene repression program involving Nr4a2, Zeb1, Bach2, and JunD and a preparedness program involving Fhl2, FosB, Stat6, Srebf2, and MPP7 in memory ILC2s. A mutually regulated balance between these two programs establishes and maintains memory. The preparedness program (e.g., Fhl2) can be activated with a subthreshold cognate stimulation, which down-regulates repressors and activates effector pathways to elicit the memory-driven phenotype.